Last Updated : October 3, 2024
Details
Project Status:
In Progress
Therapeutic Area:
Non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutation
Project Line:
Reimbursement Review
Project Sub Line:
Provisional Funding Algorithm
Project Number:
PH0054-000
Review Type: Rapid
Provisional Funding Algorithm |
|
---|---|
Draft Report Posted (Target): | 31-Oct-2024 |
Stakeholder Feedback Deadline (Target): | 7-Nov-2024 |
Final Report Posted (Target): | 4-Dec-2024 |
Last Updated : October 3, 2024